原发性痛经中西医结合药物治疗的安全性考量及中医药优势探析

Safety Considerations and Analysis of Traditional Chinese Medicine Advantages in Combined Chinese and Western Medical Drug Therapy for Primary Dysmenorrhea

摘要: 本论文旨在系统探讨原发性痛经的中西医结合药物治疗策略，重点关注其安全性及中医药的临床应用优势。本文首先分析了西药治疗的局限性与潜在风险机制，指出西药治疗虽可缓解疼痛，但常伴随胃肠道刺激、头痛等一系列副作用与不良反应。其次，阐述了中药在痛经治疗中的协同作用与安全性特征，强调中医药在治疗痛经方面具有独特的疗效和安全性，通过整体辨证和个体化施治，在实现标本兼治的同时，对全身伴随症状亦具备同步改善作用。此外，本文还突出了中医药在远期疗效稳定性、低复发率以及卫生经济学方面的显著优势。在此基础上，提出了中西医结合的临床实践路径，包括常见证型的辨证要点与治疗原则，以及中西药联合运用的策略与方法。同时，强调应加强患者健康管理及自我调护能力，涵盖生活方式干预指导和疗效自评与记录规范，以提升治疗依从性与整体效果。最后，本文总结认为，中西医结合治疗原发性痛经在安全性方面具备明显优势，中医药的整体调节和多重效益也为痛经治疗提供了重要支持。通过规范的辨证论治和系统化的患者管理，该模式有望进一步提升临床疗效，但仍需更多高质量研究加以验证和推进其标准化应用。

Abstract: This paper aims to systematically explore integrated Chinese and Western medical drug treatment strategies for primary dysmenorrhea, with a focus on their safety and the clinical application advantages of traditional Chinese medicine. This paper first analyzes the limitations and potential risk mechanisms of Western drug therapy, pointing out that while Western drugs can alleviate pain, they are often accompanied by a series of side effects and adverse reactions such as gastrointestinal irritation and headaches. Secondly, it elaborates on the synergistic effects and safety profile of traditional Chinese medicine in treating dysmenorrhea, emphasizing its unique efficacy and safety in managing menstrual pain. Through holistic pattern differentiation and individualized treatment, it addresses both the root cause and symptoms while simultaneously improving associated systemic manifestations. Furthermore, this paper highlights the significant advantages of traditional Chinese medicine in terms of long-term efficacy stability, low recurrence rates, and health economics. Building upon this foundation, it proposes a clinical practice pathway integrating traditional Chinese and Western medicine, encompassing key diagnostic principles and treatment guidelines for common syndromes, as well as strategies and methods for the combined application of Chinese and Western pharmaceuticals. At the same time, emphasis should be placed on enhancing patients’ health management and self-care capabilities, encompassing lifestyle intervention guidance and standardized self-assessment and recording of treatment efficacy, to improve treatment adherence and overall outcomes. Finally, this paper concludes that the integrated Chinese and Western medicine approach demonstrates significant advantages in safety for treating primary dysmenorrhea. Traditional Chinese medicine’s holistic regulation and multifaceted benefits also provide substantial support for dysmenorrhea management. Through standardized pattern differentiation and treatment protocols alongside systematic patient management, this model holds promise for further enhancing clinical efficacy. However, additional high-quality research is required to validate and advance its standardized application.